Skip to menu Skip to content Skip to footer

2022

Other Outputs

Peptide Antibiotics

Matthew Cooper, Mark Blaskovich, Alejandra Gallardo-Godoy, Karl Hansford, Alysha Elliott, Carig Muldoon and Bernd Becker (2022). Peptide Antibiotics. US11279733.

Peptide Antibiotics

2021

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2021). Antibacterial Agents. CN107027309.

Antibacterial Agents

2021

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2021). Antibacterial Agents. US10947271.

Antibacterial Agents

2020

Other Outputs

Non-toxic Cobalt(III) Schiff Base Complexes with Broad Spectrum Antifungal Activity

Frei, Angelo, King, A. Paden, Lowe, Gabrielle J., Cain, Amy K., Short, Francesca L., Dinh, Hue, Elliott, Alysha, Zuegg, Johannes, Wilson, Justin J. and Blaskovich, Mark (2020). Non-toxic Cobalt(III) Schiff Base Complexes with Broad Spectrum Antifungal Activity. doi: 10.26434/chemrxiv.12736505.v1

Non-toxic Cobalt(III) Schiff Base Complexes with Broad Spectrum Antifungal Activity

2020

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2020). Antibacterial Agents. EP3105244.

Antibacterial Agents

2019

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2019). Antibacterial Agents. JP6602318.

Antibacterial Agents

2019

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2019). Antibacterial Agents. AU2015/213478.

Antibacterial Agents

2019

Other Outputs

Peptide antibiotics

Gallardo-Goday, Alejandra, Cooper, Matthew, Blaskovich, Mark, Hansford, Karl and Elliott, Alysha (2019). Peptide antibiotics. WO2019084628.

Peptide antibiotics

2018

Other Outputs

Evaluating the Genome and Resistome of Extensively Drug-Resistant Klebsiella pneumoniae using Native DNA and RNA Nanopore Sequencing

Pitt, Miranda E., Nguyen, Son H., Duarte, Tânia P.S., Blaskovich, Mark A.T., Cooper, Matthew A. and Coin, Lachlan J.M. (2018). Evaluating the Genome and Resistome of Extensively Drug-Resistant Klebsiella pneumoniae using Native DNA and RNA Nanopore Sequencing. doi: 10.1101/482661

Evaluating the Genome and Resistome of Extensively Drug-Resistant Klebsiella pneumoniae using Native DNA and RNA Nanopore Sequencing

2018

Other Outputs

Glycopeptide Antibiotic Constructs

Mark Blaskovich, Matt Cooper, Andrea Ranzoni, Wanida Phetsang and Marwa Hassan (2018). Glycopeptide Antibiotic Constructs. WO/2018/102889.

Glycopeptide Antibiotic Constructs

2018

Other Outputs

Visualisation Constructs

Mark Blaskovich, Matt Cooper, Mark Butler, Rhia Stone and Wanida Phetsang (2018). Visualisation Constructs. WO/2018/102890.

Visualisation Constructs

2017

Other Outputs

Multifactorial Chromosomal Variants Regulate Polymyxin Resistance in Extensively Drug-Resistant Klebsiella pneumoniae

Pitt, Miranda E, Elliott, Alysha G, Cao, Minh Duc, Ganesamoorthy, Devika, Karaiskos, Ilias, Giamarellou, Helen, Abboud, Cely S, Blaskovich, Mark AT, Cooper, Matthew A and Coin, Lachlan (2017). Multifactorial Chromosomal Variants Regulate Polymyxin Resistance in Extensively Drug-Resistant Klebsiella pneumoniae. doi: 10.1101/134684

Multifactorial Chromosomal Variants Regulate Polymyxin Resistance in Extensively Drug-Resistant Klebsiella pneumoniae

2016

Other Outputs

Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor

Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2016). Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor. US9340517.

Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor

2015

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2015). Antibacterial Agents. WO/2015/117196.

Antibacterial Agents

2013

Other Outputs

3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

Mark Arnold Thomas Blaskovich and Pater Joseph Cassidy (2013). 3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8440653 .

3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

2013

Other Outputs

Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor

Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor. US8377925.

Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor

2013

Other Outputs

“3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8343958.

“3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

2011

Other Outputs

3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2011). 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8008291.

3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists

2010

Other Outputs

Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof

Mark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, Maher Qabar, Lauri Marie Schultz, Feng Hong, William Pratt, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2010). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7829737.

Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof

2010

Other Outputs

Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound

Blaskovich, Mark and CASSIDY P J (2010). Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound. WO2010096853-A1.

Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound